Raymond James & Associates’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$47.5K Buy
+1,000
New +$48.2K ﹤0.01% 3861
2024
Q2
Sell
-5,000
Closed -$300K 4046
2024
Q1
$300K Hold
5,000
﹤0.01% 3376
2023
Q4
$300K Buy
+5,000
New +$283K ﹤0.01% 3275

Other funds holding NTR

Raymond James & Associates's NTR Position: Q3 2024 in Review

Raymond James & Associates increased its Nutrien (NTR) stake by 11% in Q3 2024, buying an estimated $1.14M and bringing the position to 241,470 shares worth $11.6M. The position accounts for 0.01% of the portfolio, ranked #1137.

Raymond James & Associates first reported a position in NTR in Q1 2018 and has held it in 27 quarters since. The position peaked at $44.7M in Q3 2023. 600 funds tracked by Wall St. Rank hold NTR as of Q3 2024.

  • Raymond James & Associates held 241,470 shares of Nutrien worth $11.6M as of Q3 2024.
  • Raymond James & Associates bought 23,607 Nutrien shares in Q3 2024, an estimated $1.14M.
  • Nutrien made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1137 holding.
  • Raymond James & Associates first reported a position in Nutrien in Q1 2018 and has held it in 27 quarters since.
  • Raymond James & Associates's Nutrien position peaked at $44.7M in Q3 2023.
  • 600 funds tracked by Wall St. Rank held Nutrien as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.